Back to search

A phase II open-label study of cetuximab in unresectable hepatocellular carcinoma: Final results

Viktor Gruenwald, Ludwig Wilkens, M. Gebel, Tim F. Greten, Stefan Kubicka
DOI: 10.1200/jco.2007.25.18_suppl.4598
Journal of Clinical Oncology

Data up to Jan 2025

Published2007
Citations77
References0
Fields
MedicineInternal medicineOncologyGastroenterology

Total Citations Per Year

Abstract

References (0)

No references found

Cited By (0)

Loading...
A phase II open-label study of cetuximab in unresectable hepatocellular carcinoma: Final… (2007) – Journal of Clinical Oncology | Metascience Observatory Explorer